AK-104

· Akeso, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AK-104, covering 2024-08-07 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK104/Placebo Combined With Chemoradiotherapy For The Treatment of Locally Advanced Cervical Cancer [Phase 3]

See pricing